It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
When vaccination is a 'crime'

Commentary / World Mar 24, 2021

When vaccination is a 'crime'

by Peter Singer

It is not difficult to think of something better than throwing away potentially life-saving vaccines.

AstraZeneca’s pain grows as U.S. questions beleaguered COVID-19 vaccine

World Mar 24, 2021

AstraZeneca’s pain grows as U.S. questions beleaguered COVID-19 vaccine

by Suzi Ring and Marthe Fourcade

U.S. trial data showing the firm's shot to be highly effective was a welcome reprieve this week, but the good news lasted less than a day.

Vaccine techno-populism is how Europe loses

Commentary / World Mar 23, 2021

Vaccine techno-populism is how Europe loses

by Lionel Laurent

Even with four vaccines approved by EU regulators, governments are fumbling the logistics of getting needles in arms.

The ex-Pfizer scientist who became an anti-vaccination hero

World / Science & Health Mar 20, 2021

The ex-Pfizer scientist who became an anti-vaccination hero

by Steve Stecklow and Andrew Macaskill

In recent months, Michael Yeadon has emerged as an unlikely hero of the so-called anti-vaxxers, whose adherents question the safety of many vaccines, including for the coronavirus.

Scientists probe new theories on whether AstraZeneca shot linked to blood clots

World / Science & Health Mar 20, 2021

Scientists probe new theories on whether AstraZeneca shot linked to blood clots

Scientists are exploring several possibilities that might explain at least 18 reports of extremely rare blood clots in the brain that occurred in individuals in the days and weeks after receiving the AstraZeneca COVID-19 vaccine. European investigators have put forward one theory that the vaccine ...

This startup sold DNA kits to test poop. Prosecutors say it’s a fraud.

Business / Corporate Mar 20, 2021

This startup sold DNA kits to test poop. Prosecutors say it’s a fraud.

The founders of uBiome Inc. were criminally charged with a $60 million fraud in an alleged scheme that reads like a smaller-scale, lower-profile version of the collapse of Theranos Inc.

Virus keeps refusing to follow anyone’s partisan script

Commentary / World Mar 16, 2021

Virus keeps refusing to follow anyone’s partisan script

by Ramesh Ponnuru

Among the world’s rich countries, the U.S. has a middling COVID-19 death rate: better than the U.K. or Italy, worse than France or Sweden.

Japan considers COVID-19 vaccination certificates as calls from abroad grow

National Mar 15, 2021

Japan considers COVID-19 vaccination certificates as calls from abroad grow

Taro Kono, the minister in charge of vaccination efforts, offered the about-face Monday amid growing calls overseas for systems to ensure people can travel safely again.

AstraZeneca vaccine fears grow as regulators try to ease clot concerns

World Mar 15, 2021

AstraZeneca vaccine fears grow as regulators try to ease clot concerns

The drugmaker says more than 17 million doses have been administered in Europe and the U.K., with no evidence that the shot increased the risk of blood clots.

Japanese drugmaker starts AstraZeneca vaccine production

National Mar 12, 2021

Japanese drugmaker starts AstraZeneca vaccine production

Daiichi Sankyo Co. on Thursday began the vial filling and packaging of the vaccine using undiluted solutions provided by AstraZeneca.

Russia has been the Sputnik vaccine’s worst enemy

Commentary / World Mar 11, 2021

Russia has been the Sputnik vaccine’s worst enemy

by Leonid Bershidsky

Now that a peer-reviewed article in The Lancet has established Sputnik as safe and effective, the initial failure of many countries to believe in it looks like a missed opportunity.

Drugmakers in Japan struggle to keep pace in COVID-19 medicine race

National Mar 9, 2021

Drugmakers in Japan struggle to keep pace in COVID-19 medicine race

by Osamu Tsukimori

No applications for drugs specifically tailored to COVID-19 have been filed yet, as domestic pharmaceutical companies have not invested heavily enough in biomedicine.

« 1 … 33 34 35 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times